https://www.selleckchem.com/pr....oducts/sardomozide-d
001). Considering all POAF episodes (including all recurrences), 83 of the 97 patients (85.6%) received amiodarone as part of the RhC strategy. Anticoagulation was used in 58 (59.8%) patients and was suboptimal according to the study criteria in 29.5% of the patients included. Based on these results, a hospital working group developed a standardized protocol for POAF management. POAF management was heterogeneous at our institution. This article highlights the need for clear practice guidelines based on large prospect
Like
Comment
Share
